LONG TERM: 4hr ascending triangle with hidden bullish divergence + three rising vallyeys. They just got bought by AstraZeneca for $39 billion so we shall see how that affects the price, but I charted this like I would anything else. Bloomberg reports, "the offer values Alexion at $175 a share, a 45% premium to the closing price on Friday". (Not financial advice)